Yasuyoshi Arikawa

发表

Synthesis and structure of novel chiral oxazolinylferrocenes and oxazolinylferrocenylphosphines, and their rhodium(I)-complexes

K. Ohe, Y. Nishibayashi, M. Hidai, 1997 .

1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases

M. Kajino, Y. Tsukimi, N. Inatomi, 2010, Journal of Pharmacology and Experimental Therapeutics.

Iridium-Catalyzed Asymmetric Hydrosilylation of Imines Using Chiral Oxazolinyl-Phosphine Ligands

Y. Nishibayashi, M. Hidai, S. Uemura, 1999 .

Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.

Toshimasa Tanaka, Seiji Miwatashi, S. Asahi, 2005, Journal of medicinal chemistry.

Enantioselective ortho-Lithiation of Substituted Ferrocenes

K. Ohe, Y. Nishibayashi, S. Uemura, 1996 .

Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).

Terufumi Takagi, Terufumi Takagi, Teruki Hamada, 2012, Journal of medicinal chemistry.

Ruthenium(II)-catalyzed asymmetric transfer hydrogenation of ketones using chiral oxazolinylferrocenylphosphines and one of their Ru(II) complex

Y. Nishibayashi, M. Hidai, S. Uemura, 1999 .

Rhodium(I)-, iridium(I)-, and ruthenium(II)-catalyzed asymmetric transfer hydrogenation of ketones using diferrocenyl dichalcogenides as chiral ligands

Y. Nishibayashi, M. Hidai, S. Uemura, 1997 .

Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.

Terufumi Takagi, A. Hasuoka, M. Kajino, 2012, Bioorganic & medicinal chemistry.

Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action.

Teruki Hamada, T. Imaeda, F. Itoh, 2017, Bioorganic & medicinal chemistry.

Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion.

Ikuo Fujimori, F. Itoh, Y. Fujioka, 2017, Bioorganic & medicinal chemistry.

A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Male Diet-Induced–Obese Rats With Circadian Rhythm Change

M. Maruyama, Y. Habata, S. Okuda, 2017, Endocrinology.

Bombesin receptor subtype‐3‐expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus

M. Maruyama, Y. Habata, N. Amano, 2017, Brain and behavior.

monofumarate (TAK-438), A Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases. Authors

M. Kajino, Y. Tsukimi, N. Inatomi, 2010 .

Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs).

Terufumi Takagi, A. Hasuoka, F. Itoh, 2015, Bioorganic & medicinal chemistry letters.

Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists.

Seiji Miwatashi, Y. Imai, S. Ohkawa, 2008, Chemical & pharmaceutical bulletin.

Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK).

V. Feher, J. Yano, J. Zalevsky, 2016, Bioorganic & medicinal chemistry letters.

Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as p38 MAP kinase inhibitors.

T. Kawamoto, Seiji Miwatashi, S. Ohkawa, 2005, Chemical & pharmaceutical bulletin.

Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.

Terufumi Takagi, A. Hasuoka, M. Kajino, 2012, Bioorganic & medicinal chemistry.

1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases

M. Kajino, Y. Tsukimi, N. Inatomi, 2010, Journal of Pharmacology and Experimental Therapeutics.